Up a level |
2023
Borchmann, Sven (2023). A target-agnostic combination immunotherapy synergistically cures established tumors. Thesis Abstract, Universität zu Köln.
2022
Borchmann, Sven (2022). Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma. Hematol.-Am. Soc. Hematol. Educ. Program (1). S. 717 - 723. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383
Borchmann, Sven, Selenz, Carolin, Lohmann, Mia, Ludwig, Hanna, Gassa, Asmae, Braegelmann, Johannes, Lohneis, Philipp, Meder, Lydia, Mattlener, Julia, Breid, Sara, Nill, Marieke, Fassunke, Jana, Wisdom, Amy J., Compes, Anik, Gathof, Birgit, Alakus, Hakan, Kirsch, David, Hekmat, Khosro, Buettner, Reinhard, Reinhardt, H. Christian, Hallek, Michael ORCID: 0000-0002-7425-4455 and Ullrich, Roland T. (2022). Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors. J. Immunother. Cancer, 10 (10). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Garcia-Marquez, Maria A., Thelen, Martin ORCID: 0000-0002-2785-9726, Reinke, Sarah, Keller, Diandra, Wennhold, Kerstin, Lehmann, Jonas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Borchmann, Sven ORCID: 0000-0001-6662-6864, Rosenwald, Andreas, Sasse, Stephanie, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Borchmann, Peter, Engert, Andreas, Klapper, Wolfram, Von Bergwelt-Baildon, Michael, Broeckelmann, Paul J. and Schloesser, Hans A. (2022). Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma. Leukemia, 36 (3). S. 760 - 772. LONDON: SPRINGERNATURE. ISSN 1476-5551
Gerhard-Hartmann, Elena ORCID: 0000-0003-2134-2774, Goergen, Helen, Broeckelmann, Paul J., Mottok, Anja, Steinmueller, Tabea ORCID: 0000-0001-7099-1223, Grund, Johanna, Zamo, Alberto, Ben-Neriah, Susana, Sasse, Stephanie, Borchmann, Sven ORCID: 0000-0001-6662-6864, Fuchs, Michael, Borchmann, Peter, Reinke, Sarah, Engert, Andreas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Klapper, Wolfram and Rosenwald, Andreas (2022). 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. Br. J. Haematol., 196 (1). S. 116 - 127. HOBOKEN: WILEY. ISSN 1365-2141
Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141
Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO). Eur. J. Haematol., 109 (6). S. 728 - 736. HOBOKEN: WILEY. ISSN 1600-0609
Heger, Jan-Michel ORCID: 0000-0001-9463-8504 and Borchmann, Sven (2022). Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma. Leuk. Lymphoma, 63 (4). S. 768 - 771. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Heger, Jan-Michel, Mattlener, Julia, Godel, Philipp, Balke-Want, Hyatt, Sieg, Noelle, Kutsch, Nadine, Becker, Kerstin, Weiss, Jonathan, Reinhardt, H. Christian, Hallek, Michael, Borchmann, Peter, von Tresckow, Bastian and Borchmann, Sven (2022). Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing. Blood, 140. S. 3537 - 3539. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Kobe, Carsten, Baues, Christian, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Eich, Hans-Theodor and Dietlein, Markus (2022). FDG-positron emission tomography/computed tomography and new opportunities for risk stratification. Onkologie, 28 (10). S. 853 - 862. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234
Pirosa, Maria Cristina, Borchmann, Sven, Jardin, Fabrice, Gaidano, Gianluca and Rossi, Davide (2022). Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma. Hemasphere, 6 (6). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241
Selenz, Carolin, Compes, Anik, Nill, Marieke, Borchmann, Sven, Odenthal, Margarete ORCID: 0000-0002-2424-0960, Florin, Alexandra, Braegelmann, Johannes, Buettner, Reinhard, Meder, Lydia and Ullrich, Roland T. (2022). EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer. Cancers, 14 (16). BASEL: MDPI. ISSN 2072-6694
2021
Borchmann, Sven ORCID: 0000-0001-6662-6864 (2021). Liquid biopsy in Hodgkin lymphoma - moving beyond the proof of principle. Br. J. Haematol., 195 (4). S. 493 - 495. HOBOKEN: WILEY. ISSN 1365-2141
Borchmann, Sven ORCID: 0000-0001-6662-6864 (2021). An atlas of the tissue and blood metagenome in cancer reveals novel links between bacteria, viruses and cancer. Microbiome, 9 (1). LONDON: BMC. ISSN 2049-2618
Braegelmann, Johannes, Lorenz, Carina, Borchmann, Sven ORCID: 0000-0001-6662-6864, Nishii, Kazuya, Wegner, Julia ORCID: 0000-0001-8103-8040, Meder, Lydia, Ostendorp, Jenny, Ast, David F., Heimsoeth, Alena, Nakasuka, Takamasa, Hirabae, Atsuko, Okawa, Sachi, Dammert, Marcel A., Plenker, Dennis, Klein, Sebastian ORCID: 0000-0002-2188-9377, Lohneis, Philipp, Gu, Jianing, Godfrey, Laura K., Forster, Jan, Trajkovic-Arsic, Marija, Zillinger, Thomas, Haarmann, Mareike, Quaas, Alexander, Lennartz, Stefanie, Schmiel, Marcel, D'Rozario, Joshua, Thomas, Emily S., Li, Henry, Schmitt, Clemens A. ORCID: 0000-0002-4731-2226, George, Julie, Thomas, Roman K., von Karstedt, Silvia, Hartmann, Gunther, Buettner, Reinhard, Ullrich, Roland T., Siveke, Jens T., Ohashi, Kadoaki, Schlee, Martin ORCID: 0000-0003-3671-7639 and Sos, Martin L. (2021). MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nat. Commun., 12 (1). BERLIN: NATURE PORTFOLIO. ISSN 2041-1723
Momotow, Jesko, Borchmann, Sven ORCID: 0000-0001-6662-6864, Eichenauer, Dennis A., Engert, Andreas and Sasse, Stephanie (2021). Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients. J. Clin. Med., 10 (5). BASEL: MDPI. ISSN 2077-0383
2020
Broeckelmann, Paul J., Borchmann, Sven, Borchmann, Peter and Engert, Andreas (2020). Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche. J. Clin. Oncol., 38 (32). S. 3816 - 3820. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Cirillo, Melita and Borchmann, Sven (2020). An update on disease biomarkers for Hodgkin lymphoma. Expert Rev. Hematol., 13 (5). S. 481 - 489. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1747-4094
Cirillo, Melita, Craig, Alexander F. M., Borchmann, Sven and Kurtz, David M. (2020). Liquid biopsy in lymphoma: Molecular methods and clinical applications. Cancer Treat. Rev., 91. OXFORD: ELSEVIER SCI LTD. ISSN 1532-1967
Reinke, Sarah, Broeckelmann, Paul J., Iaccarino, Ingram, Garcia-Marquez, Maria, Borchmann, Sven, Jochims, Franziska, Kotrova, Michaela ORCID: 0000-0001-5394-1072, Pal, Karol, Brueggemann, Monika, Hartmann, Elena, Sasse, Stephanie, Kobe, Carsten, Mathas, Stephan, Soekler, Martin, Keller, Ulrich, Bormann, Matthias, Zimmermann, Andreas, Richter, Julia, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Schloesser, Hans, von Bergwelt-Baildon, Michael, Rosenwald, Andreas, Engert, Andreas and Klapper, Wolfram (2020). Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Blood, 136 (25). S. 2851 - 2864. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Volz, Caroline, Breid, Sara, Selenz, Carolin, Zaplatina, Alina, Golfmann, Kristina, Meder, Lydia, Dietlein, Felix, Borchmann, Sven, Chatterjee, Sampurna, Siobal, Maike, Schoettle, Jakob, Florin, Alexandra, Koker, Mirjam, Nill, Marieke, Ozretic, Luka, Uhlenbrock, Niklas, Smith, Steven, Buettner, Reinhard, Miao, Hui, Wang, Bingcheng, Reinhardt, H. Christian, Rauh, Daniel, Hallek, Michael, Acker-Palmer, Amparo, Heukamp, Lukas C. and Ullrich, Roland T. (2020). Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC. Cell Reports, 31 (4). CAMBRIDGE: CELL PRESS. ISSN 2211-1247
2019
Borchmann, Sven, Cirillo, Melita, Goergen, Helen, Meder, Lydia ORCID: 0000-0002-9547-5812, Sasse, Stephanie, Kreissl, Stefanie, Broeckelmann, Paul Jan, von Tresckow, Bastian, Fuchs, Michael, Ullrich, Roland Tillmann and Engert, Andreas (2019). Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma. J. Clin. Oncol., 37 (36). S. 3528 - 3539. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Borchmann, Sven, Joffe, Erel ORCID: 0000-0002-7883-289X, Moskowitz, Craig H., Zelenetz, Andrew D., Noy, Ariela, Portlock, Carol S., Gerecitano, John F., Batlevi, Connie L., Caron, Philip C., Drullinsky, Pamela, Hamilton, Audrey, Hamlin, Paul A., Jr., Horwitz, Steven M., Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Owens, Colette N., Palomba, M. Lia, Younes, Anas and Straus, David J. (2019). Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood, 133 (20). S. 2121 - 2130. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Sven, Mueller, Horst, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Baues, Christian, Markova, Jana, Huettmann, Andreas, Glunz, Axel, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2019). Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG). Leukemia, 33 (2). S. 439 - 447. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Cirillo, Melita, Reinke, Sarah, Klapper, Wolfram and Borchmann, Sven (2019). The translational science of hodgkin lymphoma. Br. J. Haematol., 184 (1). S. 30 - 45. HOBOKEN: WILEY. ISSN 1365-2141
Kim, Austin, I, Goergen, Helen, Engert, Andreas, LaCasce, Ann S., Maranda, Louise, Barton, Bruce and Borchmann, Sven (2019). Suicide in European Hodgkin Lymphoma Patients. Hemasphere, 3 (2). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241
2018
Borchmann, Sven, Engert, Andreas and Boell, Boris (2018). Hodgkin lymphoma in elderly patients. Curr. Opin. Oncol., 30 (5). S. 308 - 317. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X
Golfmann, Kristina, Meder, Lydia ORCID: 0000-0002-9547-5812, Koker, Mirjam, Volz, Caroline, Borchmann, Sven, Tharun, Lars, Dietlein, Felix, Malchers, Florian, Florin, Alexandra, Buettner, Reinhard, Rosen, Neal, Rodrik-Outmezguine, Vanessa, Hallek, Michael and Ullrich, Roland T. (2018). Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene, 37 (42). S. 5682 - 5694. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594
Hude, Ida, Sasse, Stephanie, Broeckelmann, Paul J., von Tresckow, Bastian, Momotow, Jesko, Engert, Andreas and Borchmann, Sven (2018). Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition. Br. J. Haematol., 181 (6). S. 837 - 841. HOBOKEN: WILEY. ISSN 1365-2141
Meder, Lydia ORCID: 0000-0002-9547-5812, Schuldt, Philipp, Thelen, Martin ORCID: 0000-0002-2785-9726, Schmitt, Anna, Dietlein, Felix, Klein, Sebastian, Borchmann, Sven, Wennhold, Kerstin, Vlasic, Ignacija, Oberbeck, Sebastian, Riedel, Richard, Florin, Alexandra, Golfmann, Kristina, Schloesser, Hans A., Odenthal, Margarete, Buettner, Reinhard, Wolf, Juergen, Hallek, Michael, Herling, Marco, von Bergwelt-Baildon, Michael, Reinhardt, H. Christian and Ullrich, Roland T. (2018). Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res., 78 (15). S. 4270 - 4282. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
2017
Borchmann, Sven and Engert, Andreas (2017). The genetics of Hodgkin lymphoma: an overview and clinical implications. Curr. Opin. Oncol., 29 (5). S. 307 - 315. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X
Borchmann, Sven, Mueller, Horst and Engert, Andreas (2017). Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude. Sci Rep, 7. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322
Borchmann, Sven and von Tresckow, Bastian (2017). Novel agents in classical Hodgkin lymphoma. Leuk. Lymphoma, 58 (10). S. 2275 - 2287. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Sasse, Stephanie, Broeckelmann, Paul J., Goergen, Helen, Pluetschow, Annette, Mueller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker and Engert, Andreas (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J. Clin. Oncol., 35 (18). S. 1999 - 2009. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
2016
Boell, Boris, Goergen, Helen, Behringer, Karolin, Broeckelmann, Paul J., Hitz, Felicitas, Kerkhoff, Andrea, Greil, Richard, von Tresckow, Bastian, Eichenauer, Dennis A., Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood, 127 (18). S. 2189 - 2193. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Sven, Hude, Ida, Muller, Horst, Haverkamp, Heinz, Burkle, Carolin, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2016). Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Sven, Mueller, Horst and Engert, Andreas (2016). Seasonal Differences in Incidence and Survival of Hodgkin Lymphoma Depend on Geographic Location of Diagnosis. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Sven, von Tresckow, Bastian and Engert, Andreas (2016). Current developments in the treatment of early-stage classical Hodgkin lymphoma. Curr. Opin. Oncol., 28 (5). S. 377 - 384. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X
Kim, Austin, Engert, Andreas, Gorgen, Helen, Maranda, Louise, LaCasce, Ann S. and Borchmann, Sven (2016). Suicide in European Hodgkin Lymphoma Patients. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2014
Jachimowicz, Ron D., Borchmann, Sven and Rothe, Achim (2014). Multi-Specific Antibodies for Cancer Immunotherapy. Biodrugs, 28 (4). S. 331 - 344. NORTHCOTE: ADIS INT LTD. ISSN 1179-190X
Rothe, Achim, Jachimowicz, Ron D., Borchmann, Sven, Madlener, Marie, Kessler, Joerg, Reiners, Katrin S., Sauer, Maike, Hansen, Hinrich P., Ullrich, Roland T., Chatterjee, Sampurna, Borchmann, Peter, Yazaki, Paul, Koslowsky, Thomas C., Engert, Andreas, Heukamp, Lukas C., Hallek, Michael and von Strandmann, Elke Pogge (2014). The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. Int. J. Cancer, 134 (12). S. 2829 - 2841. HOBOKEN: WILEY. ISSN 1097-0215